IRIS
LEONARDI, SERGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.412
EU - Europa 1.396
AS - Asia 469
SA - Sud America 65
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 4.353
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.389
IE - Irlanda 782
CN - Cina 276
IT - Italia 181
SG - Singapore 137
FI - Finlandia 135
DE - Germania 128
BR - Brasile 50
UA - Ucraina 24
SE - Svezia 23
GB - Regno Unito 19
CA - Canada 18
FR - Francia 18
NL - Olanda 18
JP - Giappone 17
AT - Austria 14
RU - Federazione Russa 14
BE - Belgio 13
IN - India 12
HK - Hong Kong 10
AR - Argentina 9
MK - Macedonia 9
TR - Turchia 6
CZ - Repubblica Ceca 4
MX - Messico 4
PH - Filippine 4
EU - Europa 3
RO - Romania 3
CL - Cile 2
EC - Ecuador 2
EG - Egitto 2
IR - Iran 2
LT - Lituania 2
MU - Mauritius 2
NO - Norvegia 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BG - Bulgaria 1
CO - Colombia 1
DZ - Algeria 1
GR - Grecia 1
KZ - Kazakistan 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PK - Pakistan 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
VE - Venezuela 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 4.353
Salva come PNG Salva come JPEG
Città #
Dublin 781
Chandler 552
Ashburn 256
Boardman 154
Princeton 143
Lawrence 138
Medford 132
Helsinki 122
Wilmington 112
Singapore 80
New York 77
Pavia 59
Shanghai 46
Jacksonville 41
Beijing 39
Nanjing 39
Los Angeles 29
Chicago 28
Milan 28
Norwalk 28
Washington 24
Fairfield 17
Hangzhou 17
Woodbridge 17
Hebei 16
Tokyo 16
Munich 14
Redwood City 14
Ann Arbor 13
Brussels 13
Nuremberg 13
Toronto 13
Changsha 11
Nanchang 11
Seattle 11
Vienna 10
Dearborn 8
Hong Kong 8
Jiaxing 8
Dallas 7
Falls Church 7
Mariglianella 7
Santa Clara 6
Shenyang 6
Falkenstein 5
Rio de Janeiro 5
Rome 5
San Francisco 5
Tianjin 5
Wuhan 5
Belo Horizonte 4
Chengdu 4
London 4
New Delhi 4
Paris 4
Skopje 4
São Paulo 4
Berlin 3
Bologna 3
Brno 3
Buenos Aires 3
Delhi 3
Eindhoven 3
Fayetteville 3
Frankfurt am Main 3
Hefei 3
Jinan 3
Las Vegas 3
Linyi 3
Miguel Hidalgo 3
Monmouth Junction 3
Ottawa 3
Parma 3
Arcore 2
Bergamo 2
Biassono 2
Borås 2
Council Bluffs 2
Des Moines 2
Desio 2
Esslingen am Neckar 2
Fortaleza 2
Fuzhou 2
Guanzate 2
Hillsborough 2
Houston 2
Manila 2
Quito 2
Redmond 2
Rockville 2
Sant'Angelo Lodigiano 2
Scuola 2
Turin 2
Voghera 2
Wenzhou 2
Yekaterinburg 2
Zhengzhou 2
Alba 1
Almaty 1
Ankara 1
Totale 3.328
Salva come PNG Salva come JPEG
Nome #
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 82
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment 80
Utilità della risonanza magnetica cardiaca nella valutazione del profilo emodinamico di pazienti con ipertensione polmonare post-embolica: uno studio di confronto con il cateterismo cardiaco destro. 77
Drug eluting stents are superior to bare metal stents to reduce clinical outcome and stent-related complications in CKD patients, a systematic review, meta-analysis and network meta-analysis 65
Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events 61
Efficacy versus safety: The dilemma of using novel platelet inhibitors for the treatment of patients with ischemic stroke and coronary artery disease 61
Strategies for reducing door to balloon time in patients with acute myocardial infarction undergoing primary angioplasty: the Pavia experience 61
Role of cardiac magnetic resonance in the avaluation of the hemodynamic profile of patients with severe chronic thromboembolic pulmonary hypertension: a comparison with right heart catheterization 60
Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion–Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease 59
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure 59
The prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy: An updated meta-analysis 58
Usefulness of cardiac megnetic resonance in assessing reverse right ventricular remodeling in patients with chronic thromboembolic pulmonary hypertension after pulmonary endarteriectomy 54
Alirocumab and cardiovascular outcomes after acute coronary syndrome 52
Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 51
null 50
Direct oral Xa inhibitors versus warfarin in patients with cancer and atrial fibrillation: a meta-analysis 49
Clinical governance programme in patients with acute coronary syndrome: Design and methodology of a quality improvement initiative 49
DAPT Score to Stratify Ischemic and Bleeding Risk after Percutaneous Coronary Intervention: An Updated Systematic Review, Meta-Analysis, and Meta-Regression of 100,211 Patients 49
Lack of implementation of guidelines recommendations for coronary revascularization in stable patients with complex disease is associated with high rates of incomplete revascularization : Analysis from the Apache study. 47
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 47
APpropriAteness of percutaneous Coronary interventions in patients with ischaemic HEart disease in Italy: The APACHE pilot study 45
Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes 45
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 45
Sotagliflozin in patients with diabetes and recent worsening heart failure 44
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX 42
Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study 42
Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: A subgroup analysis of the ARISTOTLE trial 41
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets 40
Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta-analysis 39
Meta-Analysis Comparing Potent Oral P2Y12 Inhibitors versus Clopidogrel in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention 39
Comparison of antithrombotic strategies in patients with cryptogenic stroke and patent foramen ovale: an updated meta-analysis 39
Oral aspirin or low dose of intravenous lysine acetylsalicylate in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention 39
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial 39
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 38
Parenteral antithrombotic therapy during primary percutaneous coronary intervention 38
Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers: A Randomized Crossover Study 38
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial 38
Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients with ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial 38
Dual versus triple therapy in patients on oral anticoagulants and undergoing coronary stent implantation: A systematic review and meta-analysis 37
Apixaban versus warfarin in patients with atrial fibrillation 37
Ticagrelor Alone or Conventional Dual Antiplatelet Therapy in Patients With Stable or Acute Coronary Syndromes 37
2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group 37
Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management 37
Early Complete Revascularization in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease 36
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial 36
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY 36
Primum non nocere: An updated meta-analysis on aspirin use in primary prevention of cardiovascular disease in patients with diabetes 35
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 35
Myocarditis in a 16-year-old boy positive for SARS-CoV-2 35
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2 34
Association of acute kidney injury and bleeding events with mortality after radial or femoral access in patients with acute coronary syndrome undergoing invasivemanagement: Secondary analysis of a randomized clinical trial 34
Aspirin Desensitization in Patients with Coronary Artery Disease: Results of the Multicenter ADAPTED Registry (Aspirin Desensitization in Patients With Coronary Artery Disease). 34
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY 34
The prognostic value of serial troponin measurements in patients admitted for COVID-19 34
Around the clock, around the world-reflections on 24 hours of acute cardiovascular care 34
Acute Cardiovascular Care 2019 33
Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Data From the Randomized MATRIX-Access Trial 33
Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease 33
Consistent Reduction in Periprocedural Myocardial Infarction with Cangrelor as Assessed by Multiple Definitions: Findings from CHAMPION PHOENIX (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition) 32
Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial 32
Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes 32
Acute myocardial infarction complicating ischemic stroke: is there room for cangrelor? 32
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol 32
Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study) 31
Composition, structure, and function of heart teams: A joint position paper of the ACVC, EAPCI, EACTS, and EACTA focused on the management of patients with complex coronary artery disease requiring myocardial revascularization 31
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study 31
Incidence of ventricular arrhythmias and 1-year predictors of mortality in patients treated with implantable cardioverter-defibrillator undergoing generator replacement 31
Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting 30
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study 30
Return towards normality in admissions for myocardial infarction after the lockdown removal for COVID-19 outbreak in Italy 30
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study 29
Antithrombotic Therapy in Patients With Acute Coronary Syndrome Complicated by Cardiogenic Shock or Out-Of-Hospital Cardiac Arrest: A Joint Position Paper From the European Society of Cardiology (ESC) Working Group on Thrombosis, in Association With the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI) 29
Effects of Ticagrelor, Prasugrel, or Clopidogrel at Steady State on Endothelial Function 29
Cangrelor: Review of the Drug and the CHAMPION Programme (Including PHOENIX) 29
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 29
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis 29
Clinical governance of patients with acute coronary syndromes 28
Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention 27
Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: A pooled analysis of patient-level data 27
Reply: Digoxin Use in Atrial Fibrillation: Minimizing and Refining its Use When Still Needed 27
Prognostic Implications of Declining Hemoglobin Content in Patients Hospitalized With Acute Coronary Syndromes 27
Concomitant use of proton pump inhibitors and dual antiplatelet therapy for cardiovascular outcomes 26
Association of aspirin dose and vorapaxar safety and efficacy in patients with non-st-segment elevation acute coronary syndrome (from the tracer trial) 26
The future for the Acute Cardiovascular Care Congress we shall find together 26
Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): Randomised controlled trial 26
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study 26
Short-and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: Insights from four validated bleeding scales in the CHAMPION trials 26
Post-Procedural Bivalirudin Infusion at Full or Low Regimen in Patients With Acute Coronary Syndrome 25
Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study 25
Central Adjudication Identified Additional and Prognostically Important Myocardial Infarctions in Patients Undergoing Percutaneous Coronary Intervention: Results from CHAMPION PHOENIX 24
Stent thrombosis in patients with atrial fibrillation undergoing coronary stenting in the augustus trial 24
Prospective validation of the bleeding academic research consortium classification in the all-comer PRODIGY trial 24
Reduction of Hospitalizations for Myocardial Infarction in Italy in the COVID-19 Era 23
Low-density lipoprotein cholesterol treatment and outcomes in patients with type 2 diabetes and established cardiovascular disease: Insights from TECOS 23
Prediction of radial crossover in acute coronary syndromes: derivation and validation of the MATRIX score 23
A novel approach to systematically implement the universal definition of myocardial infarction: Insights from the CHAMPION PLATFORM trial 22
A randomized, double-blind, active-controlled phase 2 trial to evaluate a novel selective and reversible intravenous and oral P2Y 12 inhibitor elinogrel versus clopidogrel in patients undergoing nonurgent percutaneous coronary intervention: The INNOVATE-PCI trial 22
Practical considerations for cangrelor use in patients with acute coronary syndromes 22
Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes: Insights from the CHAMPION percutaneous coronary intervention trial 21
Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularization 21
Totale 3.740
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.428
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.428
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020172 0 0 0 0 0 0 1 16 2 25 14 114
2020/2021214 35 4 3 6 10 13 5 71 23 21 9 14
2021/2022600 20 33 9 8 10 5 12 35 27 9 88 344
2022/20231.813 233 140 18 91 121 145 3 93 894 15 39 21
2023/2024823 60 170 39 39 74 239 9 64 2 45 31 51
2024/2025748 80 165 29 55 74 218 127 0 0 0 0 0
Totale 4.594